US$ 24.83
glp-1 gip 2ra TrimRX Eli Lilly's GIP/GLP-1 Dual Agonist
Description
When to seek medical advice: Persistent or severe nausea and vomiting that prevents adequate fluid or food intake Signs of dehydration (dark urine, dizziness, extreme thirst) Severe abdominal pain, which could indicate pancreatitis (a rare but serious side effect) Symptoms of hypoglycaemia (shakiness, sweating, confusion, rapid heartbeat) Sudden visual changes (retinopathy risk, particularly with rapid HbA1c improvement) Symptoms of gallbladder disease (severe upper abdominal pain, jaundice) Signs of severe allergic reaction (swelling of face/lips/tongue, breathing difficulty) call 999/112 Your healthcare team will typically review your HbA1c about 3 months after starting treatment and after each dose change

In Phase 2 clinical research, retatrutide demonstrated body weight reductions of up to 24.2% over 48 weeks, the largest reported for any incretin-based compound at that stage of development [8]

Singh H, Natt NK, Nim DK

168176, McIntyre, Roger S., et al

People respond differently to medication, dose timing, meals, and drink type

When GLP-1 medications aren't accessible for patients whose insurance doesn't cover GLP-1s, or who prefer not to take injections, phentermine provides a clinically meaningful alternative at a fraction of the cost
